Effectiveness of Point-of-care Lung Ultrasound for the Management of Childhood Lower Respiratory Infections

NCT05921526 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 616

Last updated 2023-11-09

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the effectiveness of point-of-care lung ultrasound versus chest X-ray for the management of childhood lower respiratory infections in a low-resource setting.

The main question it aims to answer is:

Is point-of-care lung ultrasound as effective as chest X-ray for the management of childhood LRIs in a low-resource setting?

Participants will be assigned to either a point-of-care lung ultrasound group (intervention) or a chest X-ray group (control), to compare the effect on overall case management and various clinical outcomes (time to symptom resolution, rate of antibiotic use, length of stay, treatment costs).

Conditions

  • Lower Respiratory Infection
  • LRTI
  • Pneumonia
  • Bronchiolitis

Interventions

DIAGNOSTIC_TEST

Point-of-care lung ultrasound

Participants assigned to the intervention group will receive POCLUS which will be performed by one of the trained pediatricians. The procedure involves 12 views: two anterior views, two lateral views and two posterior views on both chest walls

DIAGNOSTIC_TEST

Chest X-ray (digital images)

Participants assigned to the chest X--ray group will be sent to the Radiology department to get a CXR (digital) which will be performed by radio technicians like in routine care. Anteroposterior and/or posteroanterior chest images will be obtained. Reading/ reporting of the digital images will be done by both the radiologist and the enrolling pediatrician. The image/ clinical expert review panels (IERP/ CERP) will also have access to the images for review.

Sponsors & Collaborators

  • London School of Hygiene and Tropical Medicine

    collaborator OTHER
  • Siddhi Memorial Foundation

    collaborator OTHER
  • Nagasaki University

    lead OTHER

Principal Investigators

  • Suraj Bhattarai, MBBS, MSc, DTM&H · LSHTM/Nagasaki U/Siddhi Memorial Hospital

  • Bhim Dhoubhadel, MBBS MTM PhD DipPaed DTM&H · Nagasaki University

  • Shunmay Yeung, PhD MBBS FRCPCH MRCP DTM&H · London School of Hygiene and Tropical Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Months
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-31
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • Nepal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05921526 on ClinicalTrials.gov